IL17A and myeloid sarcoma: PBMCs from HDs and MS patients were activated with ConA and incubated with GAT107 or ACh (as described in the “Methods”), and their effects on the secretion of the pro-inflammatory cytokines IL-6 and IL-17 were examined.